Manejo nutricional na síndrome do intestino irritável (SII): restrição de FODMAPs

Abstract

Introduction: Irritable Bowel Syndrome (IBS) is a gastrointestinal disorder that affects between 5% and 10% of the world's population. Despite being a common functional intestinal disease worldwide, there are few studies that report its prevalence. Objective: To understand the effectiveness of the Low FODMAPs diet in the treatment of Irritable Bowel Syndrome. Methodology: The work is an integrative review using the electronic databases Google Scholar, SciELO (Scientific Electronic Library Online), PubMed between the months of March and June 2023. The inclusion criteria used in the research were: theses of master's degree, bibliographic review study, randomized studies, clinical trials, studies published between 2014 and 2022 written in English and Portuguese. Results: 7 articles presented the Low FODMAP protocol as a good strategy in the treatment of IBS, only 1 study reported that the reduction of FODMAP associated with another strategy. Research was able to identify that stool frequency and consistency improved, reaching type 4 on the Bristol Stool Form Scale. Conclusion: FODMAPs restriction is an efficient nutritional strategy for the treatment of patients with IBS. One of the points observed in the research was in relation to the consistency of the participants' stools, where the diet managed to improve not only the intestinal transit, but also the consistency of the stools, mainly in IBS-D. It is important to emphasize that the diet does not have a proposal to cure the disease, but to minimize the symptoms and improve the quality of life.